D. Wilson is a speaker for the Osler Institute, Insulet, and Alexion Pharmaceuticals,
Inc; has participated in an advisory board for Aegerion Pharmaceuticals and for Alexion
Pharmaceuticals, Inc; has participated in an advisory board for and has been a speaker
for Synageva BioPharma Corp; and has received research funding from Merck Sharp &
Dohme and Novo Nordisk.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical LipidologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
127
Identification
Copyright
© 2017 Published by Elsevier Inc.
